Compare CVAC & CCCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CVAC | CCCX |
|---|---|---|
| Founded | 2000 | 2024 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 934.3M |
| IPO Year | 2020 | 2025 |
| Metric | CVAC | CCCX |
|---|---|---|
| Price | $4.66 | $17.89 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.83 | N/A |
| AVG Volume (30 Days) | 1.3M | ★ 1.9M |
| Earning Date | 11-24-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 94.02 | N/A |
| EPS | ★ 0.94 | N/A |
| Revenue | ★ $83,000,117.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $23.71 | N/A |
| P/E Ratio | $4.98 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.48 | $10.03 |
| 52 Week High | $5.72 | $27.50 |
| Indicator | CVAC | CCCX |
|---|---|---|
| Relative Strength Index (RSI) | 47.92 | N/A |
| Support Level | $4.26 | N/A |
| Resistance Level | $4.68 | N/A |
| Average True Range (ATR) | 0.17 | 0.00 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 62.56 | 0.00 |
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
Churchill Capital Corp X is a blank check company.